logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shota Omori

Shizuoka Cancer Center
H指数:23
被引数:1,537

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase II study of afatinib for advanced non-small cell lung cancer with uncommon epidermal growth factor receptor mutations, including compound mutations detected by next-generation sequencing

II期研究：阿法替尼治疗携带罕见表皮生长因子受体突变（包括由下一代测序检测到的复合突变）的晚期非小细胞肺癌

international journal of oncology
IF2.8
2025-07-060
PRE
Nobuaki Mamesaya; Keita Mori; Haruki Kobayashi; Shota Omori; Ryo Ko; Kazushige Wakuda; Akira Ono; Hirotsugu Kenmotsu; Tateaki Naito; Haruyasu Murakami; Toshiaki Takahashi
A phase III study comparing weekly carboplatin plus nabpaclitaxel and daily low-dose carboplatin for concurrent chemoradiotherapy in elderly patients (≥75 years) with unresectable locally advanced NSCLC: JCOG1914

一项比较每周卡铂联合nabpaclitaxel与每日低剂量卡铂用于老年患者（≥75岁）不可切除局部晚期NSCLC同期化放疗的III期研究：JCOG1914

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Omori, S.; Kenmotsu, H.; Takahashi, T.; Nomura, S.; Harada, H.; Ishikura, S.; Ando, M.; Izumi, H.; Shinno, Y.; Oki, M.; Masuda, T.; Yokoyama, T.; Hosomi, Y.; Shimokawa, T.; Murakami, S.; Kurosaki, T.; Yoshioka, H.; Mitome, N.; Fukuda, H.; Ohe, Y.
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments

不同抗癌治疗后肺癌患者B7-H3表达的免疫组织化学分析

INVESTIGATIONAL NEW DRUGS
IF2.7
2023-04-103
PRE
Omori, Shota; Muramatsu, Koji; Kawata, Takuya; Miyawaki, Eriko; Miyawaki, Taichi; Mamesaya, Nobuaki; Kawamura, Takahisa; Kobayashi, Haruki; Nakashima, Kazuhisa; Wakuda, Kazushige; Ono, Akira; Kenmotsu, Hirotsugu; Naito, Tateaki; Murakami, Haruyasu; Sugino, Takashi; Takahashi, Toshiaki
Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study

EGFR突变的非小细胞肺癌egfr-tki治疗过程中寡残留病与失败模式的关系: 一项回顾性研究

BMC CANCER
IF3.4
2021-11-194
OAAI
Miyawaki, Taichi; Kenmotsu, Hirotsugu; Kodama, Hiroaki; Nishioka, Naoya; Miyawaki, Eriko; Mamesaya, Nobuaki; Kobayashi, Haruki; Omori, Shota; Ko, Ryo; Wakuda, Kazushige; Ono, Akira; Naito, Tateaki; Murakami, Haruyasu; Mori, Keita; Harada, Hideyuki; Endo, Masahiro; Takahashi, Kazuhisa; Takahashi, Toshiaki
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer (Oct, 10.1007/s10637-021-01191-6, 2021)

durvalumab治疗局部晚期非小细胞肺癌患者后肺炎的预后影响 (10月，10.1007/s10637-021-01191-6，2021)

INVESTIGATIONAL NEW DRUGS
IF2.7
2021-11-080
OA
Nishimura, Ari; Ono, Akira; Wakuda, Kazushige; Kawabata, Takanori; Yabe, Michitoshi; Miyawaki, Taichi; Miyawaki, Eriko; Kodama, Hiroaki; Nishioka, Naoya; Mamesaya, Nobuaki; Kobayashi, Haruki; Omori, Shota; Kenmotsu, Hirotsugu; Naito, Tateaki; Murakami, Haruyasu; Harada, Hideyuki; Takahashi, Toshiaki
Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis

局限型小细胞肺癌患者长期生存资料的回顾性分析

INVESTIGATIONAL NEW DRUGS
IF2.7
2021-10-307
PRE
Doshita, Kosei; Kenmotsu, Hirotsugu; Omori, Shota; Tabuchi, Yuya; Kawabata, Takanori; Kodama, Hiroaki; Nishioka, Naoya; Miyawaki, Eriko; Iida, Yuko; Miyawaki, Taichi; Mamesaya, Nobuaki; Kobayashi, Haruki; Ko, Ryo; Wakuda, Kazushige; Ono, Akira; Naito, Tateaki; Murakami, Haruyasu; Mori, Keita; Harada, Hideyuki; Kaneko, Takeshi; Takahashi, Toshiaki
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer

durvalumab治疗后肺炎对局部晚期非小细胞肺癌患者预后的影响

INVESTIGATIONAL NEW DRUGS
IF2.7
2021-10-1113
OAAI
Nishimura, Ari; Ono, Akira; Wakuda, Kazushige; Kawabata, Takanori; Yabe, Michitoshi; Miyawaki, Taichi; Miyawaki, Eriko; Kodama, Hiroaki; Nishioka, Naoya; Mamesaya, Nobuaki; Kobayashi, Haruki; Omori, Shota; Kenmotsu, Hirotsugu; Naito, Tateaki; Murakami, Haruyasu; Harada, Hideyuki; Takahashi, Toshiaki
Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis

在EGFR突变的软脑膜转移的非小细胞肺癌中使用先前使用的表皮生长因子受体-酪氨酸激酶抑制剂进行再攻击

INVESTIGATIONAL NEW DRUGS
IF2.7
2021-07-144
OA
Miyawaki, Taichi; Kenmotsu, Hirotsugu; Yabe, Michitoshi; Kodama, Hiroaki; Nishioka, Naoya; Miyawaki, Eriko; Mamesaya, Nobuaki; Kobayashi, Haruki; Omori, Shota; Wakuda, Kazushige; Ono, Akira; Deguchi, Shoichi; Mitsuya, Koichi; Naito, Tateaki; Murakami, Haruyasu; Mori, Keita; Harada, Hideyuki; Hayashi, Nakamasa; Takahashi, Kazuhisa; Takahashi, Toshiaki
Prognostic value of pneumonitis after durvalumab in locally-advanced non-small cell lung cancer

durvalumab治疗局部晚期非小细胞肺癌后肺炎的预后价值

ANNALS OF ONCOLOGY
IF65.4
2021-07-010
OAAI
Nishimura, Ari; Ono, Akira; Wakuda, Kazushige; Kawabata, Takanori; Yabe, Michitoshi; Miyawaki, Taichi; Miyawaki, Eriko; Kodama, Hiroaki; Nishioka, Naoya; Mamesaya, Nobuaki; Kobayashi, Haruki; Omori, Shota; Kenmostu, Hirotsugu; Naito, Tateaki; Murakami, Haruyuki; Harada, Hideyuki; Takahashi, Toshiaki
Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma

EGFR突变型非小细胞肺癌患者奥希替尼诱发间质性肺病后奥希替尼再激发的回顾性分析

INVESTIGATIONAL NEW DRUGS
IF2.7
2020-09-2126
PREAI
Kodama, Hiroaki; Wakuda, Kazushige; Yabe, Michitoshi; Nishioka, Naoya; Miyawaki, Eriko; Miyawaki, Taichi; Mamesaya, Nobuaki; Kawamura, Takahisa; Kobayashi, Haruki; Omori, Shota; Ono, Akira; Kenmotsu, Hirotsugu; Naito, Tateaki; Murakami, Haruyasu; Endo, Masahiro; Takahashi, Toshiaki
Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer

免疫检查点抑制剂单药治疗晚期非小细胞肺癌临床肿瘤负荷与疗效的关系

CLINICAL LUNG CANCER
IF3.3
2020-09-0127
PREAI
Miyawaki, Taichi; Kenmotsu, Hirotsugu; Mori, Keita; Miyawaki, Eriko; Mamesaya, Nobuaki; Kawamura, Takahisa; Kobayashi, Haruki; Omori, Shota; Wakuda, Kazushige; Ono, Akira; Naito, Tateaki; Murakami, Haruyasu; Harada, Hideyuki; Endo, Masahiro; Ohde, Yasuhisa; Takahashi, Kazuhisa; Takahashi, Toshiaki

研究方向

暂未获取到该数据
T
Tateaki Naito
H 指数:43论文数:475被引数:8,099
K
Kazushige Wakuda
H 指数:30论文数:189被引数:2,552
H
Hirotsugu Kenmotsu
H 指数:41论文数:504被引数:8,023
T
Toshiaki Takahashi
H 指数:55论文数:653被引数:1.4万
A
Akira Ono
H 指数:36论文数:296被引数:4,781
H
Haruyasu Murakami
H 指数:49论文数:507被引数:9,257
H
Haruki Kobayashi
H 指数:22论文数:206被引数:1,456
M
Masahiro Endo
H 指数:60论文数:846被引数:1.5万
N
Nobuaki Mamesaya
H 指数:19论文数:179被引数:977
H
Hideyuki Harada
H 指数:33论文数:226被引数:4,513